# Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis

> **NCT02992080** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 80 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **OTHER:** miRNAs isolation from blood samples of patients and control

## Key facts

- **NCT ID:** NCT02992080
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-12
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992080, "Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02992080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*